Umoja Biopharma
Christian R. Schubert serves as Vice President and Head of AbbVie Ventures, bringing extensive experience in the biotechnology sector. Additionally, Christian holds board observer and member positions on several boards, including Umoja Biopharma, ReAx Biotechnologies, Mozart Therapeutics, and Enthera Pharmaceuticals. Academically, Christian completed a Postdoctoral Fellowship in Neuroscience at Harvard Medical School from 2009 to 2012 and earned a Doctor of Philosophy (Ph.D.) in Biological Chemistry from the Massachusetts Institute of Technology between 2005 and 2009.
This person is not in any offices
Umoja Biopharma
3 followers
Umoja is developing a new approach to cancer therapy that retools a patient’s immune system in vivo, enhancing the body’s natural capacity to fight cancer.